INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02SPSaba Capital Management, L.P.77B / 19S · 11 late96 trades$25.89M
  3. 03FWFogarty Patrick W0B / 60S60 trades$277K
  4. 04SJSheena Jonathan0B / 57S57 trades$3.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10RJRubinstein Julie0B / 32S32 trades$5.48M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

71,584 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
19
MJ
Morrissey Michael JamesEVP, Head of Tech. Operations
INCYINCYTE CORP
Grant or award
A—
7,426 sh
Jan 16, 2026Jan 21, 2026
Page 1428 of 1790
← PrevNext →
traded Jan 16, 2026
+5d
SEC Form 4

Evidence

19
WT
Weitzel Gregory ThomasCFO
MATVMativ Holdings, Inc.
Tax withholding
F$33K
2,648 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

19
PC
Peck Kristin CDirector
BLKBlackRock, Inc.
Grant or award
A—
214 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

19
WK
Ways Douglas KirkDirector, Interim Chief Medical Officer
SPRBSPRUCE BIOSCIENCES, INC.
Option exercise
M—
1,250 sh
Dec 11, 2025Jan 21, 2026
traded Dec 11, 2025
+41dSEC Form 4

Evidence

19
HD
Harris Kimberley D.Director
GSGOLDMAN SACHS GROUP INC
Grant or award
A—
364 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

19
RC
Robbins CharlesDirector
BLKBlackRock, Inc.
Grant or award
A—
214 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

19
FT
Fitzgerald TraeChief Financial Officer
VMDVIEMED HEALTHCARE, INC.
Option exercise
M—
9,590 sh
Jan 17, 2026Jan 21, 2026
traded Jan 17, 2026
+4dSEC Form 4

Evidence

19
DH
Deneke J HeathChairman, President and CEO
SMCSummit Midstream Corp
Option exercise
M—
32.8K sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

19
SB
Sicinski Matthew B.Senior VP and CAO
SMCSummit Midstream Corp
Option exercise
M—
3,593 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

19
JD
Johnston James DavidExecutive VP, GC, CCO and Secy
SMCSummit Midstream Corp
Option exercise
M—
10.8K sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

19
WT
Weitzel Gregory ThomasCFO
MATVMativ Holdings, Inc.
Option exercise
M—
6,149 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

19
PM
Patil Neena MEVP & Chief Legal Officer
JAZZJazz Pharmaceuticals plc
Grant or award
A—
8,852 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

19
CD
Comerchero Marc D.Principal Accounting Officer
BLKBlackRock, Inc.
Grant or award
A—
551 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

19
TJ
Trahan JeremyGeneral Counsel
VMDVIEMED HEALTHCARE, INC.
Tax withholding
F$12K
1,595 sh
Jan 17, 2026Jan 21, 2026
traded Jan 17, 2026
+4dSEC Form 4

Evidence

19
TJ
Trahan JeremyGeneral Counsel
VMDVIEMED HEALTHCARE, INC.
Option exercise
M—
4,884 sh
Jan 17, 2026Jan 21, 2026
traded Jan 17, 2026
+4dSEC Form 4

Evidence

19
KN
Krishnamurthy NikkiSVP and Chief People Officer
UBERUber Technologies, Inc
Option exercise
M—
2,001 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

19
MA
Macdonald AndrewSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
4,042 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

19
WT
Weitzel Gregory ThomasCFO
MATVMativ Holdings, Inc.
Grant or award
A—
2,351 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

19
WT
Weitzel Gregory ThomasCFO
MATVMativ Holdings, Inc.
Disposition to issuer
D$27K
2,159 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

19
CP
Carr PatriciaSVP, Chief Accounting Officer
JAZZJazz Pharmaceuticals plc
Grant or award
A—
2,370 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

19
PS
Pearce SamanthaEVP, Chief Commercial Officer
JAZZJazz Pharmaceuticals plc
Grant or award
A—
3,637 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

19
WA
Wilson Mark ADirector
BLKBlackRock, Inc.
Grant or award
A—
214 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

19
CJ
Cambre JeromeVice President of Sales
VMDVIEMED HEALTHCARE, INC.
Option exercise
M—
8,525 sh
Jan 17, 2026Jan 21, 2026
traded Jan 17, 2026
+4dSEC Form 4

Evidence

19
MJ
Mault William J.Executive VP and CFO
SMCSummit Midstream Corp
Option exercise
M—
10.1K sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

19
MJ
Mault William J.Executive VP and CFO
SMCSummit Midstream Corp
Option exercise
M—
10.1K sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

19
DH
Deneke J HeathChairman, President and CEO
SMCSummit Midstream Corp
Option exercise
M—
32.8K sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

19
WK
Ways Douglas KirkDirector, Interim Chief Medical Officer
SPRBSPRUCE BIOSCIENCES, INC.
Grant or award
A—
400 sh
Dec 11, 2025Jan 21, 2026
traded Dec 11, 2025
+41dSEC Form 4

Evidence

19
VE
Vestberg Hans ErikDirector
BLKBlackRock, Inc.
Grant or award
A—
214 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

19
WK
Ways Douglas KirkDirector, Interim Chief Medical Officer
SPRBSPRUCE BIOSCIENCES, INC.
Disposition to issuer
D—
266 sh
Dec 11, 2025Jan 21, 2026
traded Dec 11, 2025
+41dSEC Form 4

Evidence

18
HJ
Hazelbaker JillSee Remarks
UBERUber Technologies, Inc
Tax withholding
F$54K
632 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

18
DD
DeSantis Deborah10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J—
120.0K sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

18
KN
Krishnamurthy NikkiSVP and Chief People Officer
UBERUber Technologies, Inc
Tax withholding
F$53K
622 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

18
DD
DeSantis Dean10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J—
120.0K sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

18
MA
Macdonald AndrewSee Remarks
UBERUber Technologies, Inc
Tax withholding
F$192K
2,259 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

18
TK
Talluri Rajendra KDirector, President and CEO
ENVXEnovix Corp
Tax withholding
F$153K
18.5K sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

18
HJ
Hazelbaker JillSee Remarks
UBERUber Technologies, Inc
Tax withholding
F$97K
1,141 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

18
MJ
Mault William J.Executive VP and CFO
SMCSummit Midstream Corp
Tax withholding
F$74K
2,757 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

18
HJ
Hazelbaker JillSee Remarks
UBERUber Technologies, Inc
Tax withholding
F$55K
644 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence

18
HC
Hoyt CaseyDirector, Chief Executive Officer
VMDVIEMED HEALTHCARE, INC.
Disposition to issuer
D$73K
10.0K sh
Jan 17, 2026Jan 21, 2026
traded Jan 17, 2026
+4dSEC Form 4

Evidence

18
DH
Deneke J HeathChairman, President and CEO
SMCSummit Midstream Corp
Tax withholding
F$220K
8,216 sh
Jan 16, 2026Jan 21, 2026
traded Jan 16, 2026
+5dSEC Form 4

Evidence